Interim Associate Provost and Dean of RSP/Director of BBRI, Julius L. Chambers Biomedical/Biotechnology Research Institute, North Carolina Central University
As a scientist, Deepak Kumar brings expertise in cancer cell and molecular biology, specifically characterizing miRNAs as therapeutic targets and biomarkers for diagnosis, prognosis and stratification. His lab currently focuses on
- characterizing molecular targets in prostate, breast, and colon cancer;
- microRNAs as biomarkers and therapeutic targets in prostate and breast cancer;
- characterizing molecular targets and signaling pathways modulated by micronutrients; and most importantly,
- enhancing minority participation in cancer research through education and training in cancer research at all levels.
As director of BBRI, Dr. Kumar serves as the scientific leader of NCCU’s JLC-BBRI research facilities in Durham and Kannapolis, NC (North Carolina Research Campus-NCRC). He is a cancer researcher and has been funded continuously by NIH since his first faculty appointment 15 years ago, most recently via R01 funding to study social epigenomics in prostate cancer and a U01 grant to study epigenetics of prostate cancer disparities. Throughout his career, he has obtained extramural funding in excess of $33 million in grant funds.
Areas of Expertise
- Cancer cell and molecular biology